Here, we analyzed nine tumor markers (CA19‐9, AFP, PSA, CEA, CA125, CYFRA, CA15‐3, SCC antigen, and NCC‐ST439) in 119 patients with pancreatic cancer and 49 with hepatocellular carcinoma, alongside 590 healthy controls. Here, CEACAM5 is linked to familial pancreatic carcinoma.